AU2001262299A1 - New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives - Google Patents

New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives

Info

Publication number
AU2001262299A1
AU2001262299A1 AU2001262299A AU6229901A AU2001262299A1 AU 2001262299 A1 AU2001262299 A1 AU 2001262299A1 AU 2001262299 A AU2001262299 A AU 2001262299A AU 6229901 A AU6229901 A AU 6229901A AU 2001262299 A1 AU2001262299 A1 AU 2001262299A1
Authority
AU
Australia
Prior art keywords
vinyl
preparation
new process
pyrrolidinone cephalosporine
cephalosporine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262299A
Inventor
Paul Hebeisen
Hans Hilpert
Roland Humm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of AU2001262299A1 publication Critical patent/AU2001262299A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Abstract

The invention relates to a new process for the preparation of a vinyl-pyrrolidinone cephalosporine derivative of the formula I The compound of the formula I, prepared according to the invention can be used for the treatment and prophylaxis of infectious diseases, especially infectious diseases caused by bacterial pathogens in particular methicillin resistent Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
AU2001262299A 2000-05-24 2001-05-18 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives Abandoned AU2001262299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00111164 2000-05-24
EP00111164 2000-05-24
PCT/EP2001/005721 WO2001090111A1 (en) 2000-05-24 2001-05-18 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives

Publications (1)

Publication Number Publication Date
AU2001262299A1 true AU2001262299A1 (en) 2001-12-03

Family

ID=8168825

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262299A Abandoned AU2001262299A1 (en) 2000-05-24 2001-05-18 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives

Country Status (16)

Country Link
US (1) US6504025B2 (en)
EP (2) EP1435357B1 (en)
JP (1) JP3994011B2 (en)
KR (1) KR100528305B1 (en)
CN (4) CN100567314C (en)
AT (2) ATE461203T1 (en)
AU (1) AU2001262299A1 (en)
CA (2) CA2408941C (en)
CY (1) CY1110298T1 (en)
DE (2) DE60141609D1 (en)
DK (2) DK1435357T3 (en)
ES (2) ES2340273T3 (en)
HK (3) HK1074620A1 (en)
MX (1) MXPA02011530A (en)
PT (2) PT1289998E (en)
WO (1) WO2001090111A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302456B1 (en) 2001-10-11 2004-01-02 Consortium für elektrochemische Industrie GmbH Process for oxidation of alcohols catalysed by nitroxyl compounds
ES2329244T3 (en) * 2003-03-27 2009-11-24 Basilea Pharmaceutica Ag CEPHALOSPORINE IN CRYSTAL FORM.
EA201070504A1 (en) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. CARBACEFEM β-LACTAM ANTIBIOTICS
AR071318A1 (en) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag BENZHIDRIL ESTER OF THE ACID (6R, 7R) -7- {2- (5-AMINO- [1,2,4] TIADIAZOL-3-IL) -2 - [(Z) -TRITILOXIIMINO] -ACETILAMINO} -3- [ (R) -1'-TERC-BUTOXICARBONIL-2-OXO- [1,3 '] BIPIRROLIDINIL- (3E) -ILIDENOMETIL] -8-OXO-5-TIA-1-AZA-BICICLO [4.2.0] OCT- 2-ENO-2-CARBOXILICO CRISTALINO; YOUR ELABORATION AND USE
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
EP2435442B1 (en) * 2009-05-25 2016-01-13 Sandoz AG Method for producing ceftobiprol medocaril
PT2569321E (en) 2010-05-10 2015-05-25 Basilea Pharmaceutica Int Ltd Oxidation process for preparing 3-formyl-cephem derivatives
CN103275104B (en) * 2013-05-15 2015-05-20 苏州明锐医药科技有限公司 Preparation method of ceftobiprole and ceftobiprole medocaril
CN105601648A (en) * 2016-03-09 2016-05-25 上海宁瑞生化技术有限公司 Method for preparing ceftobiprole through one-pot reaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620225B1 (en) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Cephalosporin derivatives
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
US5631366A (en) * 1995-01-12 1997-05-20 Hoffmann-La Roche Inc. Process for making 3-formylcephem derivatives
KR100197788B1 (en) 1995-06-30 1999-06-15 김충환 Processes for manufacturing cephem derivatives
US5883247A (en) 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
TW415949B (en) 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
PL200130B1 (en) * 1997-04-01 2008-12-31 Nabriva Therapeutics Forschung Anribacterial substituted 7-acylamino-3-(methylhydrazone) methylcephalosporins and their intermediate products
BRPI9911178B8 (en) 1998-06-15 2017-03-07 Basilea Pharmaceutica Ag 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidenemethyl) -femor derivatives, as well as pharmaceutical preparation and use thereof

Also Published As

Publication number Publication date
MXPA02011530A (en) 2003-04-25
CN100567314C (en) 2009-12-09
EP1435357A3 (en) 2006-05-03
US20020019381A1 (en) 2002-02-14
CA2583727C (en) 2010-03-30
KR100528305B1 (en) 2005-11-15
WO2001090111A1 (en) 2001-11-29
CA2583727A1 (en) 2001-11-29
HK1096091A1 (en) 2007-05-25
PT1435357E (en) 2010-04-20
CA2408941C (en) 2009-01-27
CN1301998C (en) 2007-02-28
CY1110298T1 (en) 2015-04-29
JP3994011B2 (en) 2007-10-17
CN1916006A (en) 2007-02-21
HK1096101A1 (en) 2007-05-25
ES2340273T3 (en) 2010-06-01
JP2003535059A (en) 2003-11-25
EP1289998A1 (en) 2003-03-12
EP1289998B1 (en) 2005-03-30
CN1915997A (en) 2007-02-21
DK1289998T3 (en) 2005-08-08
CN1430621A (en) 2003-07-16
CN1915997B (en) 2010-06-16
CN1170831C (en) 2004-10-13
DE60109771T2 (en) 2006-02-16
KR20030005386A (en) 2003-01-17
ATE461203T1 (en) 2010-04-15
DK1435357T3 (en) 2010-05-03
DE60109771D1 (en) 2005-05-04
CN1603327A (en) 2005-04-06
EP1435357A2 (en) 2004-07-07
CA2408941A1 (en) 2001-11-29
DE60141609D1 (en) 2010-04-29
EP1435357B1 (en) 2010-03-17
US6504025B2 (en) 2003-01-07
ATE292135T1 (en) 2005-04-15
ES2238441T3 (en) 2005-09-01
HK1074620A1 (en) 2005-11-18
PT1289998E (en) 2005-06-30

Similar Documents

Publication Publication Date Title
HK1096101A1 (en) New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
AU1261402A (en) 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
MY128650A (en) Benzoxazine antimicrobial agents
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
EP1666477A4 (en) 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative
TR200400630T4 (en) Ketolite antibiotics
MXPA05009688A (en) Naphthyridine derivatives as antibacterial agents.
CA2426680A1 (en) Process for formulation of antibiotic compounds
AU6332799A (en) Hydroxystilbene compounds used as microbicidal active substances
PT1334105E (en) PREPARATION OF N-FORMIMIDOYL-TIENAMICINE MONO-HYDROGRATE CRYSTALLINE ((MONOHYDRATED IMIPENEM)
NZ540972A (en) Novel 2,4-diamino-1,3,5-triazine derivative
EP1618106A4 (en) Carbacephem -lactam antibiotics
DE60326710D1 (en) TRICYCLIC ANTIBACTERIAL MAKROLIDE DERIVATIVES
TW200502237A (en) Cephalosporin in crystalline form
EP0947517A4 (en) Cephem derivatives
WO2003068791A3 (en) Macrolides with activity against methicillin-resistant staphylococcus aureus
WO2003068790A3 (en) Macrolide antibacterial compounds
WO2002018354A8 (en) Oxazolidinones and their use as antibacterial agents
WO2003090679A3 (en) 11-deoxy azalide antibacterials
WO2005046674A3 (en) Antibacterial compositions